References

1. Danden A, Hartmann O, Vassal G, Oberlin O. Tumeurs mésenchymateuses malignes ou sarcomes des tissus mous. Institut Gustave-Roussy. Juin 2003.


2. Gil Z, Patel S G, Singh B, Cantu G, Fliss D M, Kowalski L P, Shah J P. Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study. Cancer. 2007; 110(5) : 1033-1041. PubMed | Google Scholar


3. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, De Mascarel A, Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. International Journal of Cancer. 1984; 33(1): 37-42. PubMed | Google Scholar


4. Paulino AC, Okcu MF. Rhabdomyosarcoma. Current problems in cancer. 2008; 32(1): 7-34. PubMed | Google Scholar


5. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Benjamin RS. Adult rhabdomyosarcoma.Cancer. 2002; 95(2): 377-388. PubMed | Google Scholar


6. Nayar RC, Prudhomme F, Parise O, Gandia D, Luboinski B, Schwaab G. Rhabdomyosarcoma of the head and neck in adults: a study of 26 patients. The Laryngoscope. 1993 ; 103(12): 1362-1366. PubMed | Google Scholar


7. Bastiaannet E, Groen H, Jager PL, Cobben DCP, Van Der Graaf WTA, Vaalburg W, Hoekstra HJ. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer treatment reviews. 2004; 30(1): 83-101. PubMed | Google Scholar


8. Lawrence W, Hays DM, Heyn R, Tefft M, Crist W, Beltangady M, Wharam M. Lymphatic metastases with childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1987; 60(4) : 910-915. PubMed | Google Scholar


9. Julieron M, Robin YM, Penel N, Chevalier D. Sarcomes de la tête et du cou. EMC Oto-rhino-laryngologie. 2013;8(3):1-19.

 

 

 

 

 

 

 

 

<